Candid Therapeutics
Clinical trials sponsored by Candid Therapeutics, explained in plain language.
-
New drug CND261 tested for rheumatoid arthritis relief
Disease control OngoingThis early-stage study tests a new drug, CND261, in 47 adults with moderate to severe rheumatoid arthritis who haven't responded well to other treatments. The main goal is to check the drug's safety and how the body processes it. Researchers will also look for signs that it might…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Healthy volunteers help measure how well cizutamig absorbs under the skin
Knowledge-focused OngoingThis early-stage study in 24 healthy adults aims to measure how much of the experimental drug cizutamig reaches the bloodstream when given as a shot under the skin compared to directly into a vein. Participants will receive either the drug or a placebo and be monitored for side e…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC